Clinical Trial Update: Effect of B. Braun Peripheral Advantage Program on Complications, Indwell Time and First Stick Success of PIVC Therapy [NA]

View source ↗

Summary

Clinical trial on the B. Braun Peripheral Advantage Program for peripheral IV catheter therapy was terminated; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complications Associated with Device

Drugs mentioned

• Peripheral Advantage Program

Snippet

Sponsor: B. Braun Medical Inc. | Conditions: Complications Associated With Device | NA | Status: TERMINATED | Results posted: 2022-07-29